Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes

Wang, H; Li, Y; Lv, N; Li, YH; Wang, LL; Yu, L

Yu, L (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Yu, L (reprint author), Chinese Peoples Liberat Army Gen Hosp, BMT Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Yu, L (rep

ANNALS OF HEMATOLOGY, 2018; 97 (11): 2025

Abstract

Azacitidine and decitabine, two hypomethylating agents, are known to be effective in the treatment of high-risk myelodysplastic syndromes (MDS) and ac......

Full Text Link